Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ester Gea-Mallorquí

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Immunotherapy Advances|November 29, 2023
DC-targeting lentivectors for cancer immunotherapyEster Gea-Mallorquí, Sarah Rowland-Jones
Frontiers in Immunology|December 28, 2020
Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? Implications for Vaccine Strategies (2020)David S Kim, Sarah Rowland-Jones, Ester Gea-Mallorquí
EMBO Reports|May 10, 2023
The Preprint Club: A blueprint for community-based peer review: A blueprint for community-based peer reviewFelix Clemens Richter, Ester Gea-Mallorquí, Arthur Mortha, et al.
Nature Communications|March 22, 2022
Comparative effectiveness of the BNT162b2 and ChAdOx1 vaccines against Covid-19 in people over 50Junqing Xie, Shuo Feng, Xintong Li, et al.
Frontiers in Microbiology|August 6, 2020
HIV-2-Infected Macrophages Produce and Accumulate Poorly Infectious Viral ParticlesEster Gea-Mallorquí, Laurent Zablocki-Thomas, Mathieu Maurin, et al.
The Journal of Experimental Medicine|May 4, 2023
Intracellular trafficking of HLA-E and its regulationWanlin He, Ester Gea-Mallorquí, Huw Colin-York, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2019
Constitutive Siglec-1 expression confers susceptibility to HIV-1 infection of human dendritic cell precursorsNicolas Ruffin, Ester Gea-Mallorquí, Flavien Brouiller, et al.
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Engineering new mycobacterial vaccine design for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCGNarcís Saubi, Ester Gea-Mallorquí, Pau Ferrer, et al.
Oxford Open Immunology|May 20, 2022
Neutrophilia, lymphopenia and myeloid dysfunction: a living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathologyAmy S Codd, Stephanie J Hanna, Ewoud B Compeer, et al.
European Journal of Immunology|August 9, 2021
Clonotypic architecture of a Gag-specific CD8+ T-cell response in chronic human HIV-2 infectionEirini Moysi, Samuel Darko, Ester Gea-Mallorquí, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Immunotherapy Advances|November 29, 2023
DC-targeting lentivectors for cancer immunotherapyEster Gea-Mallorquí, Sarah Rowland-Jones
Frontiers in Immunology|December 28, 2020
Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? Implications for Vaccine Strategies (2020)David S Kim, Sarah Rowland-Jones, Ester Gea-Mallorquí
EMBO Reports|May 10, 2023
The Preprint Club: A blueprint for community-based peer review: A blueprint for community-based peer reviewFelix Clemens Richter, Ester Gea-Mallorquí, Arthur Mortha, et al.
Nature Communications|March 22, 2022
Comparative effectiveness of the BNT162b2 and ChAdOx1 vaccines against Covid-19 in people over 50Junqing Xie, Shuo Feng, Xintong Li, et al.
Frontiers in Microbiology|August 6, 2020
HIV-2-Infected Macrophages Produce and Accumulate Poorly Infectious Viral ParticlesEster Gea-Mallorquí, Laurent Zablocki-Thomas, Mathieu Maurin, et al.
The Journal of Experimental Medicine|May 4, 2023
Intracellular trafficking of HLA-E and its regulationWanlin He, Ester Gea-Mallorquí, Huw Colin-York, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2019
Constitutive Siglec-1 expression confers susceptibility to HIV-1 infection of human dendritic cell precursorsNicolas Ruffin, Ester Gea-Mallorquí, Flavien Brouiller, et al.
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Engineering new mycobacterial vaccine design for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCGNarcís Saubi, Ester Gea-Mallorquí, Pau Ferrer, et al.
Oxford Open Immunology|May 20, 2022
Neutrophilia, lymphopenia and myeloid dysfunction: a living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathologyAmy S Codd, Stephanie J Hanna, Ewoud B Compeer, et al.
European Journal of Immunology|August 9, 2021
Clonotypic architecture of a Gag-specific CD8+ T-cell response in chronic human HIV-2 infectionEirini Moysi, Samuel Darko, Ester Gea-Mallorquí, et al.
Pageof 2